Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution

Piscataway, NJ, April 3, 2025 –Camber Pharmaceuticals is excited to announce the addition of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution.
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adult patients.
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution 17.5 g/3.13g/1.6g is available in a carton of (2) – 6 ounce bottles.
To find out more information on Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, please visit: www.camberpharma.com/sodiumpotassiummagnesium
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection